Close

Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial

Go back to Peregrine Pharmaceuticals (PPHM) Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial